Grant Recipients

Delfim Duarte, MD PhD

Instituto de Investigação e Inovação em Saúde da Universidade do Porto, Portugal

Cell competition as a mechanism to eliminate minimal residual disease in acute myeloid leukemia

Amy Erbe-Gurel, PhD

University of Wisconsin

Improving Specific Targeting of Neuroblastoma Tumors through Bispecific SNIPER Antibody to Reduce Off-Target Toxicities

Dung-Fang Lee, PhD

The University of Texas Health Science Center

The Epitranscriptomic Pathway is a Therapeutic Vulnerability in p53-mutant Osteosarcoma

Vicki Huff, PhD

University of Texas M.D. Anderson Cancer Center

Assessment of a cancer preventive agent for Wilms tumor

Thais Armangue, MD, PhD

Institute for Biomedical Research August Pi i Sunyer-Barcelona, Spain

Opsoclonus myoclonus syndrome: a novel approach to antigen identification and disease modeling

Grant Funded in Partnership with The Viswanatha Family + Friends

Julien Fleurence PhD, PharmD

Baylor College of Medicine

T cells expressing a next-generation glypican-3-specific CAR incorporating IL-7 receptor signaling to cure pediatric liver cancers

Lai Man (Natalie) Wu , PhD

Cincinnati Children’s Hospital Medical Center

Identification of cellular diversity and tumor-initiating cells driving NF-to-MPNST and drug resistance by single-cell multiomics for targeted therapy

Supported in part by Hanna's Hoops 4 Healing

Alexandra Stevens, MD, PhD

Baylor College of Medicine

Predicting Atovaquone-Induced Apoptosis in Pediatric AML

Grant Rowe, MD PhD

Children’s Hospital Boston

Targeting leukemia stem cells in infant B-lymphoblastic leukemia

This grant is funded by Change a Life Foundation

Laura Perin, PhD

Children's Hospital Los Angeles

Cancer Stem Cells in Wilms Tumor: Can the Self-Renewal State Be Pushed to Nephrogenesis?

Surinder Kumar, PhD

University of Michigan

The sirtuin SIRT5 as a novel therapeutic target for Ewing's Sarcoma

This grant is funded by Peloton Magazine

Kathryn Lemberg, md, phd

Johns Hopkins University - School of Medicine

Investigating novel glutamine antagonists as a therapeutic strategy for malignant peripheral nerve sheath tumors

W. Clay Gustafson, md, phd

University of California San Francisco

Drugging the Aurora Kinase A Interactome in Neuroblastoma

Joanna Gell, md

University of California Los Angeles

Utilizing Pluripotent Stem Cells to Evaluate the Role KIT and KRAS Play in Germ Cell Development and Tumorigenesis

Masanori Hayashi, MD

John Hopkins Universtiy

Identification and targeting of circulating Ewing sarcoma stem cells

Jessica L. Heath, MD

University of Vermont

Critical Contributions of CRM1 to Pediatric Leukemogenesis.

Andras Heczey, M.D.

Texas Children's Hospital, Baylor College of Medicine

Glypican-3 specific T-cells for the adoptive immunotherapy of pediatric liver cancers

Christopher Ott, Ph.D.

Massachusetts General Hospital

Discovery of Epigenetic Factors Essential for T Cell Leukemia